Why a potent antibiotic must be delivered directly into the bloodstream to work

Health · Published 3 October 2026 · Updated 25 October 2026 Swipe more like this →

In short: Meropenem is a critical weapon against severe bacterial infections, yet it cannot be taken as a pill. Its chemical structure makes it highly unstable in the stomach and poorly absorbed by the gut. To remain effective, this carbapenem must be administered intravenously, bypassing the digestive system entirely.

Patented in 1983 and authorized for clinical use in the United States by 1996, meropenem is a cornerstone of modern medicine. The World Health Organization classifies it as critically important, as it effectively combats a wide range of infections, including meningitis, sepsis, and pneumonia. It functions by disrupting the ability of bacteria to construct their protective cell walls, typically leading to bacterial death.

The drug's primary challenge is its inherent instability. While its molecular design makes it remarkably resistant to the defensive enzymes bacteria produce to neutralize antibiotics, it is highly susceptible to hydrolysis—a process where water molecules break down the drug's active structure. This occurs not only in the body but also in liquid solutions, meaning that once reconstituted for an IV drip, the medication must be used within a strict timeframe to ensure its potency.

Oral delivery is currently impossible because the acidic environment of the stomach and the presence of specific efflux transporters in the intestines actively degrade or expel the drug before it can enter the bloodstream. Consequently, doctors must rely on intravenous administration. Because the drug is cleared from the body relatively quickly, treatment often requires prolonged infusions or frequent dosing to maintain levels high enough to kill the target bacteria.

Despite these logistical hurdles, meropenem remains a preferred choice in many hospital settings. It is generally safer than similar drugs, such as imipenem, particularly regarding the risk of seizures. Furthermore, its low protein-binding rate—only about 2%—makes it a superior option for patients with low albumin levels, where it has been shown to significantly improve survival outcomes compared to other carbapenems.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• The Last Line of Defense Against Drug-Resistant Bacteria
• The antibiotic miracle is fading as bacteria evolve to outmanoeuvre our medicines
• Why swallowing a pill is a complex journey through your digestive system
• Antimicrobials are not just one thing: they are a vast, complex chemical arsenal.
• Why this common antibiotic works better in your bladder than in your blood
• Was Rome's most notorious empress a political victim or a genuine monster of depravity?
• Well-being means coping, not only lacking a diagnosis
• Is this century-old diabetes medication the most versatile drug in modern medicine?
• Psychiatric labels track impairment, not mere oddity
• Once a celebrated insomnia cure, this sedative became a symbol of 1970s excess.
• Inflamed meninges turn headache and stiff neck into emergency
• Why this common muscle relaxant might turn your urine black, blue, or green

More in Health, medicine and disease · More in Health · Latest · A–Z · All topics